Dawson C Cooper, Efrat Abramson, Wendy C Ziai, Matthew L Flaherty, Vishank A Shah, Radhika Avadhani, Noeleen Ostapkovich, Lourdes Carhuapoma, Issam Awad, Mario Zuccarello, Daniel Hanley, Lauren H Sansing
{"title":"Intracerebral haemorrhage laterality and associations with mood and pain: a MISTIE III substudy.","authors":"Dawson C Cooper, Efrat Abramson, Wendy C Ziai, Matthew L Flaherty, Vishank A Shah, Radhika Avadhani, Noeleen Ostapkovich, Lourdes Carhuapoma, Issam Awad, Mario Zuccarello, Daniel Hanley, Lauren H Sansing","doi":"10.1136/svn-2024-003755","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The prognostic significance of the affected hemisphere in haemorrhagic stroke remains uncertain. We aimed to determine the relationship between the affected hemisphere (right or left) and differences in non-motor outcomes, including mood and pain, in patients with acute, supratentorial intracerebral haemorrhage (ICH). These non-motor outcomes are often overlooked in studies following ICH but impact patient recovery and well-being.</p><p><strong>Methods: </strong>A secondary prespecified analysis of the Minimally Invasive Surgery with Thrombolysis in Intracerebral Hemorrhage Evacuation (MISTIE) III study-a randomised, international, multicentre, placebo-controlled trial of participants with spontaneous, non-traumatic, supratentorial ICH of 30 mL or more that evaluated minimally invasive surgery with thrombolysis compared with standard medical care. Outcomes included EQ-5D three-level version (EQ-5D-3L, composite and individual non-motor components) and modified Rankin scale (mRS) scores at days 30, 180 and 365 post-ICH.</p><p><strong>Results: </strong>A total of 493 participants were eligible for analysis at day 30 following ICH. In multivariable analyses, patients with right hemispheric ICH were more likely to report problems with pain and discomfort at days 30 (β=0.257 (95% CI 0.131, 0.383)), 180 (β=0.213 (95% CI 0.090, 0.336)) and 365 (β=0.209 (95% CI 0.090, 0.328)) post-ICH. Patients with right hemispheric ICH were also more likely to report problems with anxiety and depression at days 30 (β=0.160 (95% CI 0.030, 0.291)) and 180 (β=0.171 (95% CI 0.049, 0.293)) following ICH. There were no differences in mRS scores between patients with left or right-sided haemorrhages.</p><p><strong>Conclusions: </strong>Right hemispheric lesions were associated with increased reports of mood-related symptoms (depression, anxiety) and pain in patients with acute ICH over time.</p><p><strong>Trial registration number: </strong>NCT01827046.</p>","PeriodicalId":48733,"journal":{"name":"Journal of Investigative Medicine","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Investigative Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/svn-2024-003755","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The prognostic significance of the affected hemisphere in haemorrhagic stroke remains uncertain. We aimed to determine the relationship between the affected hemisphere (right or left) and differences in non-motor outcomes, including mood and pain, in patients with acute, supratentorial intracerebral haemorrhage (ICH). These non-motor outcomes are often overlooked in studies following ICH but impact patient recovery and well-being.
Methods: A secondary prespecified analysis of the Minimally Invasive Surgery with Thrombolysis in Intracerebral Hemorrhage Evacuation (MISTIE) III study-a randomised, international, multicentre, placebo-controlled trial of participants with spontaneous, non-traumatic, supratentorial ICH of 30 mL or more that evaluated minimally invasive surgery with thrombolysis compared with standard medical care. Outcomes included EQ-5D three-level version (EQ-5D-3L, composite and individual non-motor components) and modified Rankin scale (mRS) scores at days 30, 180 and 365 post-ICH.
Results: A total of 493 participants were eligible for analysis at day 30 following ICH. In multivariable analyses, patients with right hemispheric ICH were more likely to report problems with pain and discomfort at days 30 (β=0.257 (95% CI 0.131, 0.383)), 180 (β=0.213 (95% CI 0.090, 0.336)) and 365 (β=0.209 (95% CI 0.090, 0.328)) post-ICH. Patients with right hemispheric ICH were also more likely to report problems with anxiety and depression at days 30 (β=0.160 (95% CI 0.030, 0.291)) and 180 (β=0.171 (95% CI 0.049, 0.293)) following ICH. There were no differences in mRS scores between patients with left or right-sided haemorrhages.
Conclusions: Right hemispheric lesions were associated with increased reports of mood-related symptoms (depression, anxiety) and pain in patients with acute ICH over time.
背景:患脑半球在出血性卒中中的预后意义尚不确定。我们旨在确定急性幕上脑出血(ICH)患者的受影响半球(右半球或左半球)与非运动预后(包括情绪和疼痛)差异之间的关系。这些非运动结果在脑出血后的研究中经常被忽视,但会影响患者的康复和健康。方法:对微创手术溶栓治疗颅内出血(MISTIE) III研究进行二次预先指定分析,这是一项随机、国际、多中心、安慰剂对照试验,参与者为自发性、非创伤性、幕上脑出血30ml或以上,该试验评估了微创手术溶栓与标准医疗护理的比较。结果包括EQ-5D三级版本(EQ-5D- 3l,复合和单个非运动成分)和ich后第30、180和365天的修正Rankin量表(mRS)评分。结果:共有493名参与者在ICH后第30天符合分析条件。在多变量分析中,右半脑脑出血患者在脑出血后30天(β=0.257 (95% CI 0.131, 0.383))、180天(β=0.213 (95% CI 0.090, 0.336))和365天(β=0.209 (95% CI 0.090, 0.328))更容易报告疼痛和不适问题。右半脑脑出血患者在脑出血后30天(β=0.160 (95% CI 0.030, 0.291))和180天(β=0.171 (95% CI 0.049, 0.293))报告焦虑和抑郁问题的可能性也更高。左侧和右侧出血患者的mRS评分无差异。结论:随着时间的推移,右半球病变与急性脑出血患者情绪相关症状(抑郁、焦虑)和疼痛的报告增加有关。试验注册号:NCT01827046。
期刊介绍:
Journal of Investigative Medicine (JIM) is the official publication of the American Federation for Medical Research. The journal is peer-reviewed and publishes high-quality original articles and reviews in the areas of basic, clinical, and translational medical research.
JIM publishes on all topics and specialty areas that are critical to the conduct of the entire spectrum of biomedical research: from the translation of clinical observations at the bedside, to basic and animal research to clinical research and the implementation of innovative medical care.